Back to search

Article

Computational drug repurposing identifies <i>N</i> -acetylglucosamine as a potential therapeutic compound for CLN3 Batten disease

2026-05-15

Abstract excerpt

Batten disease, also known as neuronal ceroid lipofuscinoses, is one of the most common causes of childhood dementia. It is characterized by the accumulation of lipofuscin in lysosomes, leading to loss of brain cell function, onset of dementia-like symptoms, vision loss and seizures and has extremely limited treatment options. Here, we performed computational drug repurposing analysis to identify existing compound...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
af2e0b46-7c13-5ce3-a2c6-68fa448f5b2f
DOI
10.64898/2026.05.12.724723
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Computational drug repurposing identifies <i>N</i> -acetylglucosamine as a potential therapeutic compound for CLN3 Batten diseaseDOI 10.64898/2026.05.12.724723
Select a neighboring publication to make it the new centre.